StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Vascular by Quarter

Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Reported Sales Growth YoY (%) (%)

QuarterlyAnnual

Stryker Vascular: 8.0% in Q3 2026, down 51.6 pts from a year earlier.

Latest, Q3 2026
8.0%
Period ended Sep 30, 2026
Change on a year earlier
-51.6 pts
59.6% in Q3 2025
History
20 quarters
Since Q4 2021
Sources
20
Documents cited below

Where the Q3 2026 figure comes from

Reported in Stryker Form 8-K Supplemental Sales Schedules.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Reported Sales Growth YoY (%) (%)Year on yearSource
Q3 2026Sep 30, 20268.0%-51.6 pts0000310764-26-000059|sykex991earningsq32026.htm ↗
Q2 2026Jun 30, 2026-0.7%-53.0 pts0000310764-26-000048|sykex991earningsq22026.htm ↗
Q1 2026Mar 31, 202627.5%-3.5 pts0000310764-26-000025|sykex991earningsq12026.htm ↗
Q4 2025Dec 31, 202558.1%+51.3 pts0000310764-26-000006|sykex991earningsq42025.htm ↗
Q3 2025Sep 30, 202559.6%+54.1 pts0000310764-25-000126|sykex991earningsq32025.htm ↗
Q2 2025Jun 30, 202552.3%+47.0 pts0000310764-25-000103|sykex991earningsq22025.htm ↗
Q1 2025Mar 31, 202531.0%+21.9 pts0000310764-25-000072|sykex991earningsq12025.htm ↗
Q4 2024Dec 31, 20246.8%+0.1 pts0000310764-25-000005|sykex991earningsq42024.htm ↗
Q3 2024Sep 30, 20245.5%-0.4 pts0000310764-24-000113|sykex991earningsq32024.htm ↗
Q2 2024Jun 30, 20245.3%+3.8 pts0000310764-24-000095|sykex991earningsq22024.htm ↗
Q1 2024Mar 31, 20249.1%+14.6 pts0000310764-24-000062|sykex991earningsq12024.htm ↗
Q4 2023Dec 31, 20236.7%+7.6 pts0000310764-24-000005|sykex991earningsq42023.htm ↗
Q3 2023Sep 30, 20235.9%+6.2 pts0000310764-23-000114|sykex991earningsq32023.htm ↗
Q2 2023Jun 30, 20231.5%-0.1 pts0000310764-23-000104|sykex991earningsq22023.htm ↗
Q1 2023Mar 31, 2023-5.5%-9.4 pts0000310764-23-000065|sykex991earningsq12023.htm ↗
Q4 2022Dec 31, 2022-0.9%-7.9 pts0000310764-23-000005|sykex991earningsq42022.htm ↗

Cite this data

StockData. (2026). Stryker Vascular (%), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-vasc-ww-rep

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.